Obesity is well-established as a major cardiovascular (CV) risk factor. Obesity confers a
greater risk for developing atrial fibrillation (AF), but the relation between obesity and …

Background Obesity and atrial fibrillation (AF) frequently coexist and independently increase
mortality. We sought to assess the association between obesity and adverse events in …

Although obesity is associated with the development and progression of atrial fibrillation
(AF), an obesity paradox may be present, illustrated by seemingly protective effects of …

Background and Purpose—Obesity is a risk factor for all-cause and cardiovascular death
but, despite this, an inverse relationship between overweight or obesity and a better …

Background and Purpose—Obesity has been associated with increased cardiovascular risk
in atrial fibrillation, but little is known in elderly patients with atrial fibrillation. Methods—Post …

Background Data on the relationship between body mass index (BMI), thromboembolic
events (TEE) and bleeding in patients with atrial fibrillation (AF) are controversial, and further …

Background There are conflicting data on outcomes in patients with atrial fibrillation treated
with non–vitamin K oral anticoagulants across varying body mass index (BMI). We …

Aims The prognostic implication of adiposity on clinical outcomes in atrial fibrillation (AF)
patients treated with oral anticoagulation is unclear. Methods and results A total of 17 913 …

Highlights•Obesity is an important risk factor for atrial fibrillation.•Despite “obesity paradox”
in atrial fibrillation, patient weight loss preferred.•Oral anticoagulants may be more …

In the last 40 years, concern about the obesity epidemic has increased. Data from the
current literature highlight a strong relationship between obesity and atrial fibrillation (AF) …